Evidence map›Paper›PMID 32801157›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2020

SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95/NMDAR Complex.

Lorenza Culotta, Paolo Scalmani, Ersilia Vinci, Benedetta Terragni, Alessandro Sessa, Vania Broccoli, Massimo Mantegazza, Tobias Boeckers, Chiara Verpelli

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Analysis of the off-target interaction of amyloid PET tracers with human brain sulfotransferases.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  10. Review
  11. Article
  12. Sulfation Pathways During Neurodevelopment.Frontiers in molecular biosciences · 2022
    Review
  13. Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.Frontiers in molecular neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Lorenza CulottaCNR Neuroscience Institute, 20129 Milan, Italy.
Paolo ScalmaniL'Unità Operativa Complessa di Epilettologia Clinica e Sperimentale, Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Neurological Institute Carlo Besta, 20133 Milan, Italy.ORCID 0000-0002-3992-0926
Ersilia VinciCNR Neuroscience Institute, 20129 Milan, Italy.
Benedetta TerragniL'Unità Operativa Complessa di Epilettologia Clinica e Sperimentale, Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Neurological Institute Carlo Besta, 20133 Milan, Italy.
Alessandro SessaStem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.
Vania BroccoliCNR Neuroscience Institute, 20129 Milan, Italy.
Massimo MantegazzaCNRS UMR 7275, Institut National de la Santé et de la Recherche Médicale, LabEx ICST, Institute of Molecular and Cellular Pharmacology (IPMC), Université Côte d'Azur (UCA), 06560 Valbonne-Sophia Antipolis, France.ORCID 0000-0002-1070-7929
Tobias BoeckersInstitute for Anatomy and Cell Biology, Ulm University, 89081 Ulm, Germany.
Chiara VerpelliCNR Neuroscience Institute, 20129 Milan, Italy chiara.verpelli@in.cnr.it.ORCID 0000-0003-2949-9725
Neuroscience Institute · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITCentre National de la Recherche Scientifique · FRUniversität Ulm · DEVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfotransferase 4A1 (SULT4A1) is a cytosolic sulfotransferase that is highly conserved across species and extensively expressed in the brain. However, the biological function of SULT4A1 is unclear. SULT4A1 has been implicated in several neuropsychiatric disorders, such as Phelan-McDermid syndrome and schizophrenia. Here, we investigate the role of SULT4A1 within neuron development and function. Our data demonstrate that SULT4A1 modulates neuronal branching complexity and dendritic spines formation. Moreover, we show that SULT4A1, by negatively regulating the catalytic activity of Pin1 toward PSD-95, facilitates NMDAR synaptic expression and function. Finally, we demonstrate that the pharmacological inhibition of Pin1 reverses the pathologic phenotypes of neurons knocked down by SULT4A1 by specifically restoring dendritic spine density and rescuing NMDAR-mediated synaptic transmission. Together, these findings identify SULT4A1 as a novel player in neuron development and function by modulating dendritic morphology and synaptic activity.

Indexed as

NeurogenesisAnimalsCells, CulturedDendritic SpinesDisks Large Homolog 4 ProteinFemaleHEK293 CellsHumansMiceMice, Inbred C57BLNIMA-Interacting Peptidylprolyl IsomeraseRatsReceptors, N-Methyl-D-AspartateSulfotransferasesSynapsesSynaptic TransmissionDisks Large Homolog 4 ProteinDlg4 protein, mouseNIMA-Interacting Peptidylprolyl IsomerasePin1 protein, mouseReceptors, N-Methyl-D-AspartateSulfotransferasesSult4a1 protein, mousedendritesPin1postsynaptic densitysynapse

Identifiers

PMID32801157
PMCPMC7480244
OpenAlexW3048548848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.